TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - FRESENIUS Share Price

Certificat

DE000SF70YG6

Delayed Deutsche Boerse AG 13:28:39 21/05/2024 BST
1.3 EUR +2.36% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - FRESENIUS
Current month+0.79%
1 month-6.62%
Date Price Change
21/05/24 1.3 +2.36%
20/05/24 1.27 +1.60%
17/05/24 1.25 +5.04%
16/05/24 1.19 +1.71%
15/05/24 1.17 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 21, 2024 at 01:28 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SF70YG
ISINDE000SF70YG6
Date issued 27/08/2021
Strike 40.36
Maturity Unlimited
Parity 10 : 1
Emission price 0.05
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 2.24
Lowest since issue 0.048
Spread 0.01
Spread %0.76%

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.75 EUR
Average target price
36.72 EUR
Spread / Average Target
+32.34%
Consensus